These data show that restoration of STING activity in tumor cells can augment antitumor responses to STING agonist therapy even in STING-intact hosts and indicate that both tumor and host-derived STING, together, can play a critical role in promoting antitumor immunity. Here, STING1 is linked to neoplasm.